Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesis
- PMID: 40601305
- DOI: 10.1097/HEP.0000000000001403
Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesis
Retraction of
-
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.Hepatology. 2018 Sep;68(3):1042-1056. doi: 10.1002/hep.29898. Epub 2018 Jun 1. Hepatology. 2018. Retraction in: Hepatology. 2025 Sep 01;82(3):E114. doi: 10.1097/HEP.0000000000001403. PMID: 29601088 Free PMC article. Retracted.
Similar articles
-
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.Hepatology. 2018 Sep;68(3):1042-1056. doi: 10.1002/hep.29898. Epub 2018 Jun 1. Hepatology. 2018. Retraction in: Hepatology. 2025 Sep 01;82(3):E114. doi: 10.1097/HEP.0000000000001403. PMID: 29601088 Free PMC article. Retracted.
-
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.Lab Invest. 2018 Nov;98(11):1465-1477. doi: 10.1038/s41374-018-0101-0. Epub 2018 Aug 24. Lab Invest. 2018. PMID: 30143751 Free PMC article.
-
Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice.Pain. 2005 Nov;118(1-2):254-62. doi: 10.1016/j.pain.2005.08.024. Epub 2005 Oct 3. Pain. 2005. PMID: 16202530
-
[The H1 and H2 histamine receptors].Allerg Immunol (Paris). 1988 Nov;20(9):317-25. Allerg Immunol (Paris). 1988. PMID: 2905135 Review. French.
-
Characterization and distribution of histamine H1- and H2-receptors in precapillary vessels.J Cardiovasc Pharmacol. 1984;6 Suppl 4:S587-97. doi: 10.1097/00005344-198406004-00005. J Cardiovasc Pharmacol. 1984. PMID: 6083401 Review.
References
REFERENCE
-
- Kennedy L, Hargrove L, Demieville J, Karstens W, Jones H, DeMorrow S, et al. Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 −/− mice and human cholangiocarcinoma tumorigenesis. Hepatology. 2018;68:1042–1056.
Publication types
LinkOut - more resources
Full Text Sources